Overview

Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction

Status:
Completed
Trial end date:
2021-02-26
Target enrollment:
Participant gender:
Summary
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction
Phase:
Phase 2
Details
Lead Sponsor:
Recardio, Inc.
Treatments:
Lenograstim